arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

UroGen Pharma Ltd.

URGN

$46.97 ▲ +1.34 (+2.93%) at close

12 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Neutral

auto_awesome

Analytical Summary

UroGen Pharma Ltd. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Operating Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $2.3B

Dividend Yield —

Revenue Growth 21.4% ↗

Op. Margin -113.7% ↘

ROIC -639.8% ↘

FCF / Share $-3.38 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -1.19

info Valuation on last close. End-of-day price, Aug 7, 2026.

12-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$109.79M

↑ +21.4% —

Net Income Profit after all expenses

$-153.49M

↓ -21.0% —

Operating Margin Operating profit as % of sales

-113.7%

↓ -6.2% 2th

FCF / Share Free cash flow per share

$-3.38

↓ -49.4% —

Long-Term Debt Long-term obligations

$125.00M

↑ +2.7% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

100

Financial Health

100

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 20-F ↗
Revenue Growth YoY (%)	21.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+168%)	9.3% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+16%)	28.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+257%)	34.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+324%)	307.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3740%)	65450.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+818025%)	-98.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1330%)	-86.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1177%)	-53.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-768%)	—	—	—
EPS Growth YoY (%)	-7.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	16.6% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	26.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	3.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-21.0% Weak ↓ Weak Declining Year-over-year change in net income	-24.1% Weak ↓ Weak Declining Year-over-year change in net income	6.9% Fair ↑ Fair Improving Year-over-year change in net income	0.9% Caution ↑ Caution Improving Year-over-year change in net income	13.7% Fair ↑ Fair Improving Year-over-year change in net income	-22.2% Weak ↑ Weak Improving Year-over-year change in net income	-39.0% Weak ↑ Weak Improving Year-over-year change in net income	-278.3% Weak ↑ Weak Improving Year-over-year change in net income	-930.4% Weak Weak Year-over-year change in net income	84.7% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	-49.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	14.8% Fair → Fair Stable Year-over-year change in free cash flow	31.0% Excellent Excellent Year-over-year change in free cash flow	-0.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	19.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	23.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	91.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	1429.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	249.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	13.1% Good Good Compound annual revenue growth over 3 years	-89.9% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	56.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	449.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	136.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	51.1% Excellent Excellent Compound annual revenue growth over 5 years	22.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 20-F ↗
Operating Margin (%) (%)	-113.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-858%)	-107.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-814%)	-79.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-628%)	-122.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-919%)	-192.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1381%)	—	—	—	-244.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1730%)	4.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-70%)	—	—
Effective Tax Rate (%) (%)	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.3% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	-4.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	-139.8% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1265%)	-140.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1270%)	-123.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1130%)	-170.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1522%)	-230.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2022%)	—	—	—	-245.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2143%)	-11.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-192%)	—	—
FCF Margin (%) (%)	-148.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-107.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-92.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-136.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-178.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-120.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	19.9% Good Good Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.80x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 20-F ↗
Return on Invested Capital (%)	-639.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-87.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-204.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-982.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1111.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-135.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-85.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	3.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-60.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-62.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-77.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-103.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-74.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	3.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	145.5% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+870%)	—	156.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+945%)	122.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+719%)	—	-133.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-989%)	-58.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-489%)	-84.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-660%)	-29.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-295%)	-11.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-77.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-620%)	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 20-F ↗
Debt to Equity (x)	-1.19x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-298%)	-13.83x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-2405%)	-1.51x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-352%)	-1.09x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-282%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—
Net Debt (USD)	$14.26M	$-50.25M	$3.55M	$42.13M	$-44.36M	$-52.86M	$-49.69M	$-101.32M	$-37.00M	$-21.36M	$-17.98M	$-3.87M
Debt / EBITDA (x)	-1.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.26x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.52x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.25x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 20-F ↗
Revenue per Share (USD)	$2.28	$2.11	$2.87	$2.82	$2.15	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-3.19	$-2.96	$-3.55	$-4.81	$-4.96	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.38	$-2.26	$-2.66	$-3.85	$-3.83	—	—	—	—	—	—	—
Book Value per Share (USD)	$-2.18	$-0.21	$-2.01	$-3.86	$0.37	$4.35	$8.58	$5.56	$4.98	$7.07	—	—
Tangible Book Value per Share (USD)	$-2.18	$-0.21	$-2.01	$-3.86	$0.37	$4.35	$8.58	$5.56	$4.98	$7.07	—	—
Basic Weighted Avg Shares (shares)	48.12M	42.88M	28.83M	22.81M	22.35M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 20-F ↗
Working Capital (USD)	$139.61M	$230.19M	$137.97M	$104.99M	$92.01M	$94.18M	$129.15M	$88.78M	$67.44M	$18.90M	—	—
LT Debt (USD)	$125.00M	$121.73M	$98.55M	$97.54M	$0.00	—	—	—	—	—	—	—
Total Equity (USD)	$-105.47M	$-8.80M	$-65.21M	$-89.36M	$8.41M	$96.36M	$180.30M	$90.09M	$68.52M	$16.31M	$16.28M	$3.16M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 20-F ↗
Sales/Revenue/Turnover (USD)	$109.79M	$90.40M	$82.71M	$64.36M	$48.04M	$11.80M	$18.00K	$1.13M	$8.16M	$17.53M	—	—
Depreciation Expense (USD)	$307.00K	$329.00K	$802.00K	$924.00K	$831.00K	$400.00K	$300.00K	$400.00K	$200.00K	$213.00K	$113.00K	—
Net Income, GAAP (USD)	$-153.49M	$-126.87M	$-102.24M	$-109.78M	$-110.82M	$-128.48M	$-105.15M	$-75.66M	$-20.00M	$-1.94M	$-12.69M	—
Operating Cash Flow (USD)	$-162.44M	$-96.77M	$-76.38M	$-87.56M	$-84.89M	$-105.89M	$-71.02M	$-37.33M	$-9.57M	$4.19M	$-7.17M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 37 quarters

UroGen Pharma Ltd.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare URGN with peers